Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-APOC3
Go back to Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-APOC3| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 83.03 +0.29 (0.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $82.74 | 52 Week High | $8.22 | |||
| Open | $82.87 | 52 Week Low | $3.07 | |||
| Day High | $85.47 | P/E | N/A | |||
| Day Low | $82.71 | EPS | $-1.30 | |||
| Volume | 115,332 | |||||
